Pharma's Almanac TV
PA TV
Follow the Journey
Become a Sponsor
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
Rooster Bio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Research
CDMO
CRO
Excipients
Pharmaceutical Equipment
Pharmaceutical Intermediates
Supply Chain Logistics
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
By The Numbers
API
87 Articles Available
1
4
Can't find what you're looking for? Try our
advanced search
.
Small-Volume Manufacturing
Benefits of Integrated Small-Volume Manufacturing Capabilities
PAP-Q1-20-CL-008
Complex Manufacturing
Enabling Commercial Manufacturing for Highly Complex Small Molecule Drugs Through Process Engineering and Technological Innovation
PAP-Q1-20-CL-017
Quality
Impurity Identification in Small-Molecule APIs
PAO-01-20-CL-005
Collaborative Culture
Tech Transfer and Scale-Up for Custom APIs Driven by a Collaborative Culture
PAP-Q3-19-CL-001
Global Network
Applying an Established and Continuously Upgraded Global Network for CDMO Services
PAP-Q3-19-CL-002
Regulatory Starting Materials (RSMs)
Integrated Outsourcing from RSMs to APIs
PAP-Q2-2019-CL-004
Commercialization
Supporting Commercialization with Specialized Technologies
PAP-Q2-2019-CL-034
Sterile
Quality and Experience Crucial for Sterility Assurance
PAP-Q2-2019-CL-014
Small Molecule API
Supporting Client Projects for CDMO Success
PAP-Q1-2019-CL-030
3D Printing
Aprecia and Cycle Team to Develop 3D-Printed Orphan Drugs
PAO-M12-17-NI-018
CDMO
Alcami to Manufacture Darinaparsin
PAO-M11-17-NI-016
API
Right-First-Time Innovation Approach Drives Continual Investment
PAP-Q4-17-CL-003
API
Achieving Efficient Pharmaceutical Synthesis with Process Intensification
PAP-Q4-17-CL-003
API
Becoming Bioavailable
MCO-M07-17-NI-021
API
Cambrex Invests in New Highly Potent API Manufacturing Capacity
PAO-M08-17-NI-016
Biologics
Propagating a Full Spectrum of Services for ADC Development and Manufacture
PAP-Q2-17-CL-007
API
Small Molecule Injectable Manufacturing: Challenges and Complexities
PAP-Q2-17-CL-013
Innovation
Flow Chemistry: Pathway for Continuous API Manufacturing
SCM-M05-NI-023
Innovation
Pharma’s Great Automation Migration
PMP-M05-17-NI-001
API
Connecting the Dots for Clients
PTV-M03-17-IN-009
Anticipating Future Guidelines By Utilizing The Latest Technologies In Particle Characterization
POP-M03-17-NI-001
MicroJet Reactor (MJR) for APIs
PTV-M11-16-AP-028
Filling a Market Need
PTV-M11-16-AP-016
Energizing Client Portfolios with Patient-Friendly Dosage Forms
PAP-Q1-17-CL-001
1
4
»
